SweBioFertil: Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
Study Details
Study Description
Brief Summary
This study aims to investigate the microbiome of women with previously proven fertility who plan to become pregnant.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The women will be recruited at the time of removal of a copper or hormonal intrauterine device (IUD) or removal of a contraceptive implant at the barnmorskemottagningar (midwife clinics) in Stockholm's county in Sweden. A total of 500 women will be included in the study and will be followed until conception or up to the end of 1 year, whichever comes first. If conception occurs, the woman will be followed throughout pregnancy. Participant recruitment will take place over a period of two years.
Study Design
Outcome Measures
Primary Outcome Measures
- The microbiome profile and metabolome associated with time to pregnancy, miscarriage, and live birth will be assessed. [2024]
Secondary Outcome Measures
- Microbiome profiles and metabolome related to obstetric outcomes [2024]
- The microbiome profile for women above age >38 and women below <38. [2024]
- The influence of BMI, medications and comorbidities on the microbiome profiles. [2024]
- Microbiome profile for those women who don't conceive within a year. [2024]
- The metabolome of the recognized microbiome for women with normal pregnancy outcomes [2024]
- The metabolome of the recognized microbiome for women who develop miscarriage or other pregnancy complications [2024]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women with a previous live birth in the past 5 years and planning a new pregnancy with the same male partner.
-
18-40 years of age
-
Swedish personal identity number and a Swedish address (to send a sampling self-kit)
-
Sufficient understanding of spoken and written Swedish or English to provide informed consent and complete the web-based questionnaire.
Exclusion Criteria:
- Women who do not have a child yet and plan to cease their contraception.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Reproductive Medicine, Karolinska University Hospital | Stockholm | Huddinge | Sweden | 141 57 |
Sponsors and Collaborators
- Karolinska Institutet
- Karolinska University Hospital
Investigators
- Study Chair: Lars Holmgren, Professor, Karolinska Institutet
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Dnr 2021-03765